XML 54 R37.htm IDEA: XBRL DOCUMENT v3.23.4
Stockholders' Equity (Tables)
 3 Months Ended
Nov. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-based Compensation Expense
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):
  Three months ended
  November 30, 2023 November 30, 2022
Restricted stock units
 $ 42  $ 38 
Employee stock purchase plan 4  4 
Total $ 46  $ 42 
Schedule of Share-based Compensation Information
The following represents the stock-based compensation information as of the period indicated (in millions):
  November 30, 2023
Unrecognized stock-based compensation expense – restricted stock units $ 82 
Remaining weighted-average period for restricted stock units expense 1.5 years
Schedule of Common Stock Outstanding
The following represents the common stock outstanding for the periods indicated:
Three months ended
November 30, 2023 November 30, 2022
Common stock outstanding:
Beginning balances
 131,294,422  135,493,980 
Vesting of restricted stock
 1,766,775  1,861,678 
Purchases of treasury stock under employee stock plans
 (526,028) (523,407)
Treasury shares purchased(1)(2)
 (3,887,738) (2,600,951)
Ending balances
 128,647,431  134,231,300 
(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remained under the 2022 Share Repurchase Program.
(2)In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of the Company’s common stock. As part of the 2023 Share Repurchase Program, the Company entered into an accelerated share repurchase (“ASR”) agreement with a bank in September 2023 to repurchase $500 million of the Company’s common stock. During the first quarter of 2024, the ASR transaction was completed, and 3.9 million shares were delivered under the ASR agreement at an average price of $128.61. The final number of shares delivered upon settlement of the ASR agreement was determined based on a discount to the volume weighted average price of the Company’s common stock during the term of the agreement. As of November 30, 2023, 3.9 million shares had been repurchased for $500 million, excluding excise tax, and $2.0 billion remains available under the 2023 Share Repurchase Program approved in September 2023.